This article is more than 5 years old. Information may no longer be current.

STAAR Surgical receives CE mark for new ICL design

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — STAAR Surgical has received a CE mark for a new Visian Implantable Collamer Lens design, the company announced in a press release.

The V4c design has a proprietary port in the center of the ICL to increase fluid flow inside of the eye and to eliminate the need for a YAG peripheral iridotomy before implantation.

The company has issued two patents on the technology, which has been approved for the myopic range of -0.5 D to -18 D and the cylinder power of +0.5 to +6.0 in the toric ICL models, the release said.

"This technology marks another key advancement from our product pipeline of planned new features designed to provide continuous enhancements to the Visian ICL technology," Barry G. Caldwell, CEO of STAAR Surgical, said in the press release.

The company is planning a pre-market release of the V4c model in four sites and 100 eyes before a full product launch, the release said. Because some key Asia-Pacific markets have yet to launch the V4b model, STAAR will seek approval for the new model instead.